首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1477254

乾眼症市場，依產品類型、依配方類型、依配銷通路、地理位置

Dry Eye Disease Market, By Product Type, By Formulation Type, By Distribution Channel, By Geography

出版日期: 2024年04月03日 | 出版商:

Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年乾眼症市場價值為73.3億美元，預計到2031年將達到132.6億美元，2024年至2031年的年複合成長率(CAGR)為8.8%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	73.3 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	8.80%	2031 年價值預測：	132.6 億美元

圖 1. 乾眼症市場佔有率 (%)，依地區分類，2024 年

乾眼症，也稱為乾燥性角結膜炎，是一種淚液和眼表的多因素疾病，會導致不適、視力障礙和淚膜不穩定的症狀，並對眼瞼間眼表造成潛在損害。它伴隨著淚膜滲透壓的增加和眼表的發炎。由於人口老化和數位設備的更多使用，乾眼症在全球範圍內成為一個日益嚴重的問題，導致眨眼頻率降低和睜眼時間增加。儘管乾眼症通常被認為是一種輕微的、令人討厭的疾病，但它會對生活品質和生產力產生負面影響。

市場動態：

全球乾眼症市場是由全球老年人口不斷成長所推動的，老年人口主要因年齡相關的淚液產生減少而受到乾眼症的影響。此外，長時間使用智慧型手機、筆記型電腦和平板電腦等數位設備會導致眼睛疲勞，導致乾眼症，進而推動市場成長。然而，對乾眼症的治療選擇、自我保健和管理缺乏認知，尤其是在發展中國家，這是主要的市場限制。市場參與者有機會探索產品開發的新途徑，包括創新的人工淚液輸送方法和旨在解決乾眼症症狀和體徵的聯合療法。

研究的主要特點：

該報告對全球乾眼症市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球乾眼症市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球乾眼症市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球乾眼症市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 9 章：競爭格局

公司簡介
- Novartis AG
- Alcon Inc.
- I-MED Pharma Inc
- Sun Pharmaceutical Industries Ltd.
- Novaliq GmbH
- Cipla Inc.
- AbbVie Inc.
- Lupin
- Otsuka Holdings Co., Ltd.
- Santen Pharmaceutical Co., Ltd
- Cambium Medical Technologies
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
- Abbott
- Adrif Vision
- Grevis Pharmaceuticals Pvt. Ltd.
- AFT Pharmaceuticals
- URSAPHARM Arzneimittel GmbH
- Altacor

第 10 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI5438

The dry eye disease market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to reach USD 13.26 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 7.33 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.80%	2031 Value Projection:	US$ 13.26 Bn

Figure 1.Dry Eye Disease Market, Share (%), By Region, 2024

Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the interpalpebral ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface. Dry eye disease is a growing problem worldwide due to aging populations and greater use of digital devices, leading to decreased blink rates and more time spent with eyes open. Although often thought of as a mild, nuisance disease, dry eye can negatively impact quality of life and productivity.

Market Dynamics:

The global dry eye disease market is driven by the rising geriatric population globally which is majorly affected by dry eye disease due to age-related decreasing tear production. Furthermore, increasing usage of digital devices, such as smartphones, laptops, and tablets, for extended periods are majorly straining eyes leading to dry eyes, thereby driving the market growth. However, lack of awareness about treatment options, self-care, and management of dry eye disease especially in developing nations act as major market restraints. Market participants have the chance to explore new avenues in product development, including innovative delivery methods for artificial tears and combination therapies aimed at addressing both the signs and symptoms of dry eye disease.

Key Features of the Study:

This report provides an in-depth analysis of the global dry eye disease market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global dry eye disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Novartis AG, Alcon Inc., I-MED Pharma Inc, Sun Pharmaceutical Industries Ltd., Novaliq GmbH, Cipla Inc., AbbVie Inc., Lupin, Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd, Cambium Medical Technologies, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Abbott, Adrif Vision, Grevis Pharmaceuticals Pvt. Ltd., AFT Pharmaceuticals, URSAPHARM Arzneimittel GmbH, and Altacor.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global dry eye disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dry eye disease market.

Detailed Segmentation-

Product Type:
- Cyclosporine
- Corticosteroids
- Lifitegrast
- Ocular Lubricant
- Punctal Plugs
- Others
Formulation Type:
- Liquid
- Gel
- Ointment
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Supermarket/Hypermarket
- Other Stores
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Alcon Inc.
- I-MED Pharma Inc
- Sun Pharmaceutical Industries Ltd.
- Novaliq GmbH
- Cipla Inc.
- AbbVie Inc.
- Lupin
- Otsuka Holdings Co., Ltd.
- Santen Pharmaceutical Co., Ltd
- Cambium Medical Technologies
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
- Abbott
- Adrif Vision
- Grevis Pharmaceuticals Pvt. Ltd.
- AFT Pharmaceuticals
- URSAPHARM Arzneimittel GmbH
- Altacor

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Formulation Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Dry Eye Disease Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Dry Eye Disease Market, By Product Type, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cyclosporine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Lifitegrast
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Ocular Lubricant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Punctal Plugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Dry Eye Disease Market, By Formulation Type, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Ointment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Dry Eye Disease Market, By Distribution Channel, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Supermarket/Hypermarket
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Other Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Dry Eye Disease Market, By Region, 2019 - 2031, (USD BN)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Alcon Inc.
- I-MED Pharma Inc
- Sun Pharmaceutical Industries Ltd.
- Novaliq GmbH
- Cipla Inc.
- AbbVie Inc.
- Lupin
- Otsuka Holdings Co., Ltd.
- Santen Pharmaceutical Co., Ltd
- Cambium Medical Technologies
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Bausch & Lomb Incorporated
- Abbott
- Adrif Vision
- Grevis Pharmaceuticals Pvt. Ltd.
- AFT Pharmaceuticals
- URSAPHARM Arzneimittel GmbH
- Altacor